Pharmacological study of a new hypoglycaemic sulphonamide: glisoxepid (RP 22410).
D000284:Administration, Oral; D000818:Animals; D001381:Azepines / Q000494:pharmacology; D001786:Blood Glucose; D004285:Dogs; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects; D051379:Mice; D010080:Oxazoles / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects; D010180:Pancreatectomy; D010477:Perfusion; D051381:Rats; D013268:Stimulation, Chemical; D013453:Sulfonylurea Compounds / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology
D001381:Azepines; D001786:Blood Glucose; D007328:Insulin; D010080:Oxazoles; D013453:Sulfonylurea Compounds; D014044:Tolbutamide